Marimed (MRMD) Other Operating Expenses (2013 - 2026)
Marimed's (MRMD) quarterly Other Operating Expenses came in at $8.1 million in Q1 2026, down 16.0% year-on-year from $9.6 million in Q1 2025, and up 1.44% on a QoQ basis from $8.0 million in Q4 2025.
Marimed (MRMD) Other Operating Expenses (2013 - 2026) Analysis & Trends
Marimed (MRMD) has 14 years of Other Operating Expenses data on file, last reported at $8.1 million in Q1 2026.
- On a quarterly basis, Other Operating Expenses fell 16.0% year-over-year to $8.1 million in Q1 2026; TTM through Mar 2026 was $32.5 million, a 6.59% decrease from a year earlier, with the FY2025 full-year figure at $34.1 million, up 1.91% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $8.1 million, up from $8.0 million in the prior quarter.
- Over the last five years, Other Operating Expenses for MRMD reached as high as $9.6 million in Q1 2025 and fell as low as $3.7 million in Q1 2022.
- Historically, Other Operating Expenses has averaged $7.4 million across 5 years, with a median of $8.0 million in 2025.
- Across the five-year window, Other Operating Expenses soared 149.42% in 2022 and fell 16.0% in 2026, its largest moves.
- Year by year, Other Operating Expenses stood at $8.8 million in 2022, then slipped by 6.44% to $8.2 million in 2023, then retreated by 10.21% to $7.4 million in 2024, then rose by 7.78% to $8.0 million in 2025, then rose by 1.44% to $8.1 million in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were $8.1 million in Q1 2026, $8.0 million in Q4 2025, and $8.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Marimed | 23.85 Mn | 14.02 Mn | 15.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.10 Mn |
| Dec 31, 2025 | 7.98 Mn |
| Sep 30, 2025 | 8.03 Mn |
| Jun 30, 2025 | 8.41 Mn |
| Mar 31, 2025 | 9.64 Mn |
| Dec 31, 2024 | 7.40 Mn |
| Sep 30, 2024 | 8.97 Mn |
| Jun 30, 2024 | 8.80 Mn |
| Mar 31, 2024 | 8.23 Mn |
| Dec 31, 2023 | 8.25 Mn |
| Sep 30, 2023 | 7.38 Mn |
| Jun 30, 2023 | 7.32 Mn |
| Mar 31, 2023 | 5.76 Mn |
| Dec 31, 2022 | 8.81 Mn |
| Sep 30, 2022 | 5.19 Mn |
| Jun 30, 2022 | 4.19 Mn |
| Mar 31, 2022 | 3.70 Mn |
| Dec 31, 2021 | 3.66 Mn |
| Sep 30, 2021 | 2.08 Mn |
| Jun 30, 2021 | 3.12 Mn |